PTC Therapeutics, Inc. Revenue 2011–2025
PTC Therapeutics, Inc. annual/quarterly revenue history and growth rate from 2011 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- PTC Therapeutics, Inc. revenue for the quarter ending March 31, 2026 was 272.6 M, a 76.83% decrease year-over-year.
- PTC Therapeutics, Inc. revenue for the twelve months ending March 31, 2026 was 1.8 B, a 132.67% increase year-over-year.
- PTC Therapeutics, Inc. annual revenue for 2025 was 1.7 B, a 114.51% increase from 2024.
- PTC Therapeutics, Inc. annual revenue for 2024 was 806.8 M, a 13.97% decrease from 2023.
- PTC Therapeutics, Inc. annual revenue for 2023 was 937.8 M, a 34.20% increase from 2022.
- PTC Therapeutics, Inc. annual revenue for 2022 was 698.8 M.
Ptc Therapeutics Inc. (PTCT) — Frequently Asked Questions
Ptc Therapeutics Inc. (PTCT) is a publicly traded US company. It has a market capitalization of $6.48B. In fiscal 2025 it reported revenue of $1.73B and net income of $683M. Explore PTCT's stock price, financial statements, earnings history, margins and key ratios below.
What is Ptc Therapeutics Inc.'s market cap?
Ptc Therapeutics Inc. (PTCT) has a market capitalization of $6.48B.
What is the PTCT stock price?
PTCT trades at $73.35 (-0.45% on the day).
How much revenue does Ptc Therapeutics Inc. make?
Ptc Therapeutics Inc. reported revenue of $1.73B in fiscal 2025.
Is PTCT profitable?
In fiscal 2025, Ptc Therapeutics Inc. reported net income of $683M.
What is PTCT's P/E ratio?
Based on diluted EPS, PTCT has a price-to-earnings (P/E) ratio of about 9.4.